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Background: Nowadays it remains a controversial issue whether a correlation exists between the apoptosis rate of
tumor tissue and the prognosis of the patients. We aimed to explore the prognostic significance of apoptosis index
of human osteosarcoma tissue.
Methods: The technique of terminal DNA breakpoints in situ 3 - hydroxy end labeling (TUNEL) was used to detect
and analysis apoptosis index in 56 osteosarcoma specimens. The relationships between apoptosis index of tumor
tissue and long term survival of patients as well as pathologic classification, tumor clinical stages, tumor size and
level of serum alkaline phosphatase were analyzed.
Results: Our studies showed the cases with high apoptosis index had significantly longer survival time. Apoptosis
index in osteosarcoma tissue was correlated with tumor size and level of serum alkaline phosphatase but not with
pathologic classifications and clinical stages of tumor.
Conclusion: Our results demonstrated that apoptosis index of osteosarcoma tissue combined with serum alkaline
phosphatase could used as valid indicators to predicate the malignant level and prognosis of osteosarcoma cases,
which would contribute to enhance efficacy of clinical treatments for osteosarcoma.
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Osteosarcoma is the most frequent highly malignant
bone-tumor with a peak manifestation during the second
and third decade of life. Survival rates in osteosarcoma
have improved considerably from 20 to 65% since the
1980s with the advent of multiagent chemotherapy [1,2].
Further improvement in survival has not been achieved
owing to lack of well-validated prognostic markers and
the problem of non-response to chemotherapy [3,4].
The identification of patients with a bad response to
therapy at the time of diagnosis would facilitate already
a preoperative stratification of chemotherapy or a more
aggressive regime to increase survival.
It’s the recent realization of malignant tumors may grow
due to not only limitless proliferation but also athanasy of* Correspondence: doctorwx@hotmail.com
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reproduction in any medium, provided the ortumor cells that provides absolute new directions in basic
and clinical tumor research. Thus apoptosis, namely the
programmed cell death, is among the spotlights of aca-
demic area of tumor [5,6], which has been found playing
an important role during the occurrence and development
of tumors [7,8]. However, to this day it remains a contro-
versial issue whether the correlation of apoptosis rate with
the degree of malignancy and prognosis of the patients
exist [9]. Furthermore, what about the relationship be-
tween apoptosis and osteosarcoma? Few studies yet have
been undertaken to explore the predictive value of apop-
tosis on the therapy for osteosarcoma cases.
We hypothesized that it were the unstable experimen-
tal techniques for detecting different phase of apoptosis
of tumor cells that had influenced the results of apoptotic
rates. In our study apoptotic index (AI) in paraffin sec-
tions of osteosarcoma tissue was detected and calculated
through technique of terminal deoxynucleotidyl transfer-
ase (TdT)-mediated dUTP-digoxigenin nick end labeling. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Positive expression of apoptotic osteosarcoma cells
(Tunel staining ×400).
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osteosarcoma tissue and the long-term survival of pa-
tients and interrelated influencing factors were analyzed.
Materials and methods
Patients
Paraffin-embedded tissues were obtained from 56 pa-
tients with limb osteosarcoma who had undergone limb
salvage surgery by the same senior surgeon between 1994
and 2006. The diagnosis of patients was confirmed by a
pathologist. Serial sections of 4μm thickness were used
for H&E staining and immunohistochemistry. The group
included 26 cases of osteoblastic type, 16 cases of fibro-
blastic type, 10 cases of chondroblastic type and 4 cases
of mixed type according to pathologic classification [10].
There were 36 males and 20 females aged from 14 to 37
years in the group. All the 56 patients underwent the
same regimes of neoadjuvant chemotherapy (high-dose
methotrexate adriamycin and cisplatin). Patients were
followed up for 2 to 8.5 years (median 5.8 years). Our
study was approved by an Investigational Review Board
and followed principle in the Declaration of Helsinki.
Terminal DNA breakpoints in situ 3 - hydroxy end
labeling (TUNEL)
The TUNEL staining kit was from Beohringer Mannheim
GmbH. Staining precedures were as following: (1) The tis-
sue sections were deparaffinized by immersing slides in xy-
lene, and rehydrated by sequentially immersing the slides
through graded ethanol washes. (2)The activity of en-
dogenous peroxidase was quenched by adding 0.3%
H2O2 for 30 minutes and then washed in 10 mmol/l
PBS (pH 7.4), 3 times for 5 min each. (3)The sections
were digested with 20 μg/ml Proteinase K for 25 mi-
nutes at room temperature, and washed in 10 mmol/l
PBS (pH 7.4), 3 times for 5 min each. (4)The TUNEL reac-
tion mixture was added to each section followed by incu-
bating in a humid chamber for 60 min at 37°C. (5) They
were then washed in 10 mmol/l PBS (pH 7.4), 3 times
for 5 min each, and incubated with peroxidase conju-
gated anti-fluorescein antibody in a humid chamber for
30 min. at 37°C. Then they were washed in 10 mmol/l
PBS (pH 7.4), 3 times for 5 min each. (6) The tissue sec-
tions were stained with DAB for 10 min, counterstained
with hematoxylin, dehydrated, cleared in xylene and
cover slipped.
Microscope observation
Morphological features of apoptotic cells: TUNEL staining
was able to distinguish apoptotic cells and apoptotic bodies
with surrounding cells. Proteins were located in the nuclei,
were brown in color, with condensed nucleoplasm and in
close proximity to the nuclear membrane, or were present
as diffuse staining. In addition, apoptotic bodies were alsofound in the sections (Figures 1 and 2). The apoptotic
index of the cases in this group was 0% ~ 17.8% (median
8.45%), the positive rate was 53.6% (30/56).
Determination of the apoptotic Index (AI)
The apoptotic index was determined by counting the
percentage of positive cells from at least 500 neoplastic
nuclei at 400× magnification. For each slide, five most
obvious positive staining fields were examined. Based
on the AI, cells were divided into four grades: grade I:
apoptotic cells not detected or AI <1% correspondent
to negative cells, (−); grade II: AI< 5% of cells were (+);
grade III: 5%~10% of cells were (++); grade IV: >10% of
cells were (+++).
Statistical analysis
A statistical software package (SPSS 10.0) was used to
carry out the statistical analysis. The correlation analysis
of the rank correlation coefficient between two groups
was carried out using the Wilcoxon W test. The correl-
ation analysis of the rank correlation coefficient between
multiple independent samples was carried out using the
Kruskal-Wallis tests.
Results
Relationship between gross tumor volume and AI of
osteosarcoma
Our study showed that the grade of apoptotic index in
osteosarcoma tissue of gross tumor volume ≥ 10cm was
significantly different compared with that of gross tumor
volume < 10 cm (Table 1).
Relationship between levels of patient’s serum alkaline
phosphatase and AI of osteosarcoma
The normal value of people’s serum alkaline phosphatase
(ALP) ranges from 15 to115 IU/L. According to literature
Figure 2 Apoptotic bodies (Tunel staining ×400).
Table 2 Relationship between levels of serum ALP and AI
of osteosarcoma
ALP* AI
- + ++ +++
Elevated 18 4 4 0
Normal 8 8 8 6
* Wilcoxon W rank test: Z=−2.332, P<0.05.
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in children and adolescent phase concerning elevation
of ALP value at physiological skeleton growth period.
Wilcoxon W rank test revealed the grade of AI in the
ALP elevated group was significantly different compared
with that in the normal ALP group (Table 2).
Relationship between AI of osteosarcoma and the long
term survival of patients
The grade of AI in patients with long term survival >5
years was statistically higher compared with that in pa-
tients with long term survival ≤ 5 years, and the results
demonstrated that the grade of AI in the long term sur-
vival of patients with osteosarcoma was significantly dif-
ferent compared with that in the group with survival
time less than 5 years (Table 3).
Discussion
The concept of apoptosis has a far-reaching impact on
cancer awareness and research. Although apoptotic cells
have certain characteristic morphology, they are often
not easy to detect or visualize especially when they dis-
play as the early apoptotic cells [12,13]. When a cell
undergoes apoptosis, endogenous DNA endonucleases
are activated, and the DNA is degraded into fragments
of about 180~200 bp or its multiples. The 3′-OH ends
are exposed, and thus TUNEL staining can be used toTable 1 Relationship between gross tumor volume and AI
of osteosarcoma
Tumor volume * A I (cases)
- + ++ +++
≥10 cm 4 6 8 6
<10 cm 22 6 4 0
*:Wilcoxon Rank test analysis : Z=−2.994 , P<0.01.detect the fragmented DNA [14,15]. Our results showed
that TUNEL staining in paraffin sections was a reliable
method for detecting apoptosis. In addition to chromatin
condensation during the early apoptosis process, the nu-
clei of apoptotic cells become narrowed, and the cyto-
plasm is condensed after the release of apoptotic bodies.
Therefore, TUNEL staining is a more reliable method
than morphology observation alone [16]. On the whole,
TUNEL staining has the advantages of detecting more
apoptotic cells, thus resulting to elevation of the apop-
totic index. Therefore it could reflect the extent of apop-
tosis more accurately, and should be regarded as a
simple, fast and efficient method for analysis of tumor
apoptosis cells.
It is a controversial issue whether a relationship exists
between the apoptosis rate and the degree of malignancy
and the prognosis of the patients [17]. Until now it has
been generally believed that the higher the apoptosis
rate, the slower the tumor growth, thus resulting in a
better prognosis [18,19]. We found that the positive
apoptosis rate in osteosarcoma by TUNEL staining was
53.6%, which was higher than that of normal tissues.
The patients with higher long-term survival had a higher
apoptosis rate. In contrast to this study, Lipponen et al.
[20] determined the cell apoptotic index of bladder can-
cer and breast cancer according to morphological cri-
teria, and found that poor prognosis correlated with
high apoptotic index. Moreover, AI was related signifi-
cantly to high proliferation rate of cancer cells. Local re-
ports on osteosarcoma had similar results [21]. We
analyzed the reasons for this and hypothesized that it
could be related to experimental techniques and the dif-
ferent observation phase of apoptosis. If the apoptosis
levels of tumor at different stages were different, the re-
sults would be different too. The emergence of early
apoptotic cells may be positively correlated with tumorTable 3 Relationship between AI of osteosarcoma and the
long term survival of patients
Long term survival* AI
- + ++ +++
>5 years 3 6 8 5
≤5years 23 6 4 1
* Wilcoxon W rank test: Z= −2.407,P<0.05.
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at the latter stage could explain the inhibition of tumor
growth more exactly. Because the TUNEL technique has
high resolution for apoptotic bodies, it is more accurate
than the standard morphology analysis.
We presumed that the apoptosis level of tumor tissue
was elevated owing to speed up of tumor growth as well
as to centrical hypoxia necrosis of larger tumor [22], and
the genuine reasons deserved further probing. Elevation
of serum ALP of patients with malignant bone tumor
often predict more osteogenesis activity of tumor cells,
hithreto, ALP is confirmed as a valuable index to assess
prognosis and therapeutic results of osteosarcoma [23].
Although the combination of modern surgery and sys-
temic chemotherapy has improved osteosarcoma treat-
ment dramatically, near half of postoperative patients
die from pulmonary metastasis of osteosarcoma cells
that have poor response to chemotherapy [24]. Defi-
ciency of valid indicators for predicting malignant degree
and prognosis of osteosarcoma is attributed to one of
reasons of therapeutic failure [25]. Detection of AI is not
among the routine pathologic test subjects for tumor
specimen, however we believe that testing of AI in bi-
opsy tissue of osteosarcoma before treatment, combining
with serum index such as ALP, would help for compre-
hensive analyze and judgment of malignance and prog-
nosis of osteosarcoma cases, thereby for guidance to
chemotherapy and surgical protocol.
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